Richard C. Pötter

Richard C. Pötter's AcademicInfluence.com Rankings

Richard C. Pötter

Medical

#2660

World Rank

#3091

Historical Rank

Oncology

#170

World Rank

#176

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Richard C. Pötter Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Richard C. Pötter's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. (2006) (1411)
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. (2005) (1321)
Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer (2011) (661)
Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. (2007) (490)
Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. (2016) (484)
Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). (2010) (483)
5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial (2016) (417)
Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. (2007) (413)
Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience. (2015) (378)
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies (2018) (364)
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy (2012) (337)
Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. (2005) (312)
The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results. (2006) (291)
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer (2018) (277)
Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. (2009) (232)
Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. (2016) (231)
High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group. (1999) (230)
The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results. (2006) (222)
Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. (2009) (222)
Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. (1999) (214)
Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study. (2016) (208)
GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. (2005) (206)
Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy. (2012) (206)
Endovascular Brachytherapy for Prophylaxis of Restenosis After Femoropopliteal Angioplasty: Results of a Prospective Randomized Study (2000) (205)
Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. (2005) (201)
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. (2018) (198)
Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. (2004) (198)
Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. (2003) (185)
Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study. (2016) (180)
Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial (2017) (176)
Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy. (2011) (175)
The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. (2002) (171)
Curative radiation therapy for locally advanced cervical cancer: brachytherapy is NOT optional. (2014) (163)
Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. (2003) (160)
Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors. (2001) (156)
Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow‐up project of the German–Austrian DAL‐HD studies (2010) (154)
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. (2021) (149)
Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy. (2008) (146)
Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. (2001) (145)
Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study. (2016) (144)
Aspects of MR Image Distortions in Radiotherapy Treatment Planning (2001) (138)
Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma. (2000) (137)
Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. (2007) (136)
Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy (2012) (123)
Local tumor control and morbidity after one to three fractions of stereotactic external beam irradiation for uveal melanoma. (2000) (123)
Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery. (2011) (123)
Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook. (2003) (123)
Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. (2000) (121)
Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. (2009) (121)
Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, pathoanatomic structures, and organs at risk. (2006) (118)
11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer. (2006) (114)
Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95. (2013) (114)
Adaptive management of cervical cancer radiotherapy. (2010) (111)
Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer. (2008) (111)
Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma (2008) (107)
The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trial. (2003) (103)
Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. (2001) (103)
LINAC based stereotactic radiotherapy of uveal melanoma: 4 years clinical experience. (2003) (100)
Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. (2009) (99)
Locally recurrent breast cancer: pulse dose rate brachytherapy for repeat irradiation following lumpectomy-- a second chance to preserve the breast. (2002) (98)
Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer (2002) (97)
Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group. (2005) (97)
Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study. (2011) (94)
Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study. (2014) (94)
Dosimetric impact of interobserver variability in MRI-based delineation for cervical cancer brachytherapy. (2013) (93)
TP53 Genotype but Not p53 Immunohistochemical Result Predicts Response to Preoperative Short-Term Radiotherapy in Rectal Cancer (2002) (90)
Quality of life changes during conformal radiation therapy for prostate carcinoma (2000) (90)
Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer: a multi-institutional study. (2013) (89)
A multicentre comparison of the dosimetric impact of inter- and intra-fractional anatomical variations in fractionated cervix cancer brachytherapy (2013) (88)
Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies. (2006) (87)
Adaptive image guided brachytherapy for cervical cancer: A combined MRI-/CT-planning technique with MRI only at first fraction (2013) (85)
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer. (2018) (84)
Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial. (2000) (84)
Uncertainties in image guided adaptive cervix cancer brachytherapy: impact on planning and prescription. (2013) (83)
Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. (2006) (83)
Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study. (1998) (82)
Patterns of care for brachytherapy in Europe: updated results. (2010) (82)
Radiation therapy in the treatment of endometrial stromal sarcoma. (2001) (81)
Erythropoietin for patients undergoing radiotherapy: a pilot study. (1999) (80)
GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance. (2016) (80)
Primary treatment of endometrial carcinoma with high-dose-rate brachytherapy: results of 12 years of experience with 280 patients. (1997) (80)
Inter- and intraobserver variation in HR-CTV contouring: intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. (2008) (78)
Nomogram prediction for overall survival of patients diagnosed with cervical cancer (2012) (77)
Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial. (2012) (77)
Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints. (2007) (76)
The updated ESTRO core curricula 2011 for clinicians, medical physicists and RTTs in radiotherapy/radiation oncology. (2012) (76)
Uncertainties when using only one MRI-based treatment plan for subsequent high-dose-rate tandem and ring applications in brachytherapy of cervix cancer. (2006) (73)
In-vivo dosimetry for gynaecological brachytherapy: physical and clinical considerations. (2005) (73)
Health-Related Quality of Life in Locally Advanced Cervical Cancer Patients After Definitive Chemoradiation Therapy Including Image Guided Adaptive Brachytherapy: An Analysis From the EMBRACE Study. (2016) (72)
Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri (1998) (66)
Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients. (2007) (65)
MRI Assessment of Cervical Cancer for Adaptive Radiotherapy (2009) (65)
Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study. (2005) (65)
High-dose-rate (HDR) brachytherapy with or without external beam radiotherapy in the treatment of primary vaginal carcinoma: long-term results and side effects. (2003) (63)
Effects of geometric distortion in 0.2T MRI on radiotherapy treatment planning of prostate cancer. (2004) (63)
The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin's disease: evolution in the tradition of the DAL/GPOH studies. (2004) (61)
Advancements in brachytherapy. (2017) (61)
Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis. (2005) (60)
Interstitial brachytherapy alone after breast conserving surgery: interim results of a German-Austrian multicenter phase II trial. (2004) (60)
The benefit of Beam's eye view based 3D treatment planning for cervical cancer. (1999) (60)
Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis. (2000) (60)
Acute Side Effects during 3-D-Planned Conformal Radiotherapy of Prostate Cancer (2003) (59)
Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer (2010) (59)
Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer. (2002) (59)
Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study. (2018) (59)
Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival. (2002) (58)
3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: clinical experience with 3 year follow-up. (2006) (58)
Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator. (2007) (58)
Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results. (2012) (57)
A linac-based stereotactic irradiation technique of uveal melanoma. (2001) (57)
Variation of treatment planning parameters (D90 HR-CTV, D 2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints. (2010) (57)
Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: A comparison of spatial dose distribution within a matched-pair analysis (2011) (56)
Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study. (1997) (54)
Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial. (1998) (53)
Can protons improve SBRT for lung lesions? Dosimetric considerations. (2008) (53)
High-risk clinical target volume delineation in CT-guided cervical cancer brachytherapy: Impact of information from FIGO stage with or without systematic inclusion of 3D documentation of clinical gynecological examination (2013) (53)
Dose volume parameter D2cc does not correlate with vaginal side effects in individual patients with cervical cancer treated within a defined treatment protocol with very high brachytherapy doses. (2010) (53)
Posttraumatic stress disorder after high-dose-rate brachytherapy for cervical cancer with 2 fractions in 1 application under spinal/epidural anesthesia: incidence and risk factors. (2014) (53)
Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer. (2011) (53)
Ultrasound-Guided Interstitial Brachytherapy in the Treatment of Advanced Vaginal Recurrences from Cervical and Endometrial Carcinoma (2006) (52)
Change in Patterns of Failure After Image-Guided Brachytherapy for Cervical Cancer: Analysis From the RetroEMBRACE Study. (2019) (52)
Cone-beam CT-based delineation of stereotactic lung targets: the influence of image modality and target size on interobserver variability. (2012) (52)
Abdominal cancer during early childhood: a dosimetric comparison of proton beams to standard and advanced photon radiotherapy. (2008) (52)
Gynecologic radiation therapy: Novel approaches to image-guidance and management (2011) (51)
Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy. (2014) (51)
Image Guided Adaptive Brachytherapy in cervix cancer: A new paradigm changing clinical practice and outcome. (2016) (50)
Image-guided adaptive brachytherapy for cervix carcinoma. (2008) (50)
Radiation dose associated with local control in advanced anal cancer: retrospective analysis of 129 patients. (2008) (50)
Late gastrointestinal and urogenital side-effects after radiotherapy--incidence and prevalence. Subgroup-analysis within the prospective Austrian-German phase II multicenter trial for localized prostate cancer. (2012) (50)
New inverse planning technology for image-guided cervical cancer brachytherapy: description and evaluation within a clinical frame. (2009) (50)
Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy. (2005) (50)
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer (2018) (50)
Treatment of endometrial carcinoma with high‐dose‐rate brachytherapy alone in medically inoperable stage I patients (1998) (49)
Endovascular brachytherapy for prophylaxis against restenosis after long-segment femoropopliteal placement of stents: initial results. (2001) (49)
Prescribing, recording, and reporting in endovascular brachytherapy. Quality assurance, equipment, personnel and education. (2001) (49)
Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy. (2013) (48)
Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy (2009) (48)
Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer. (2018) (48)
Quality control in interstitial brachytherapy of the breast using pulsed dose rate: treatment planning and dose delivery with an Ir-192 afterloading system. (2001) (48)
The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer. (2000) (48)
Feasibility of transrectal ultrasonography for assessment of cervical cancer (2013) (47)
Direct reconstruction of the Vienna applicator on MR images. (2009) (47)
Impact of a micromultileaf collimator on stereotactic radiotherapy of uveal melanoma. (2003) (46)
Physics Aspects of Quality Control in Radiotherapy, Edited by W.P.M. Mayles, R. Lake, A. McKanzie, E.M. Macaulay, H.M. Morgan, T.J. Jordan and S.K. Powley, The Institute of Physics and Engineering in Medicine, York, 1999, 286 pp. ISBN: 0-904181-91-X (2000) (46)
PTV margins should not be used to compensate for uncertainties in 3D image guided intracavitary brachytherapy. (2010) (46)
Health related quality of life and patient reported symptoms before and during definitive radio(chemo)therapy using image-guided adaptive brachytherapy for locally advanced cervical cancer and early recovery - a mono-institutional prospective study. (2015) (45)
Uncertainty analysis for 3D image-based cervix cancer brachytherapy by repetitive MR imaging: assessment of DVH-variations between two HDR fractions within one applicator insertion and their clinical relevance. (2013) (45)
Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer - An alternative to MRI for target definition? (2016) (45)
Comparative Treatment Planning on Localized Prostate Carcinoma (2005) (44)
Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study. (2005) (44)
Automatic real-time surveillance of eye position and gating for stereotactic radiotherapy of uveal melanoma. (2004) (43)
Impact of IMRT and leaf width on stereotactic body radiotherapy of liver and lung lesions. (2005) (43)
Image guidance in radiation therapy for better cure of cancer (2020) (42)
Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial (2012) (42)
Four years with FALCON - an ESTRO educational project: achievements and perspectives. (2014) (42)
Interobserver Comparison of CT and MRI-Based Prostate Apex Definition Clinical Relevance for Conformal Radiotherapy Treatment Planning (2002) (41)
A volumetric analysis of GTVD and CTVHR as defined by the GEC ESTRO recommendations in FIGO stage IIB and IIIB cervical cancer patients treated with IGABT in a prospective multicentric trial (EMBRACE). (2016) (40)
Radiation-induced morphological changes in the vagina (2012) (39)
Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy: Results From the EMBRACE I Study. (2020) (39)
Dosimetric comparison of stereotactic body radiotherapy in different respiration conditions: a modeling study. (2006) (39)
Accelerated Partial Breast Irradiation with Iridium-192 Multicatheter PDR/HDR Brachytherapy (2004) (38)
Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160-1172). (2005) (37)
Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort. (2019) (37)
Comparison of DVH parameters and loading patterns of standard loading, manual and inverse optimization for intracavitary brachytherapy on a subset of tandem/ovoid cases. (2010) (37)
Radiotherapy alone for invasive vaginal cancer: outcome with intracavitary high dose rate brachytherapy versus conventional low dose rate brachytherapy (2001) (37)
Quality assurance in MR image guided adaptive brachytherapy for cervical cancer: Final results of the EMBRACE study dummy run. (2015) (36)
Combining transrectal ultrasound and CT for image-guided adaptive brachytherapy of cervical cancer: Proof of concept. (2016) (36)
Results of fast neutron therapy of adenoid cystic carcinoma of the salivary glands. (1999) (36)
Betulinic Acid a Radiosensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines (2010) (35)
A noninvasive eye fixation and computer-aided eye monitoring system for linear accelerator-based stereotactic radiotherapy of uveal melanoma. (2001) (35)
Up-front centralized data review and individualized treatment proposals in a multicenter pediatric Hodgkin's disease trial with 71 participating hospitals: the experience of the German-Austrian pediatric multicenter trial DAL-HD-90. (2002) (34)
Hepatotoxicity in irradiated nephroblastoma patients during postoperative treatment according to SIOP9/GPOH. (1994) (34)
Normalized sensitometric curves for the verification of hybrid IMRT treatment plans with multiple energies. (2003) (34)
[Significance of a rectal balloon as internal immobilization device in conformal radiotherapy of prostatic carcinoma]. (1999) (34)
Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy. Preliminary results of the German-Austrian multicenter trial. (2004) (34)
Results of primary and adjuvant radiotherapy in the treatment of mixed Müllerian tumors of the corpus uteri. (1999) (34)
Accelerated partial breast irradiation with interstitial implants: risk factors associated with increased local recurrence. (2011) (34)
Anemia Is a Significant Prognostic Factor in Local Relapse-Free Survival of Premenopausal Primary Breast Cancer Patients Receiving Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil Chemotherapy (2008) (34)
Isodose surface volumes in cervix cancer brachytherapy: Change of practice from standard (Point A) to individualized image guided adaptive (EMBRACE I) brachytherapy. (2018) (33)
Time course of late rectal- and urinary bladder side effects after MRI-guided adaptive brachytherapy for cervical cancer (2013) (33)
Value of Magnetic Resonance Imaging Without or With Applicator in Place for Target Definition in Cervix Cancer Brachytherapy. (2016) (33)
Assessment of Improved Organ at Risk Sparing for Advanced Cervix Carcinoma Utilizing Precision Radiotherapy Techniques (2008) (33)
Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90. (2003) (32)
Hodgkin's disease in children: combined modality treatment for stages IA, IB, and IIA. Results in 356 patients of the German/Austrian Pediatric Study Group. (1994) (32)
Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervix cancer radiotherapy (2013) (32)
Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: evaluation of 175 patients treated with 150 Gy from 1981-1989. (1997) (32)
Practice patterns of radiotherapy in cervical cancer among member groups of the Gynecologic Cancer Intergroup (GCIG). (2007) (32)
Results of high dose 106-ruthenium irradiation of choroidal melanomas. (1986) (31)
Do clinicians and patients agree regarding symptoms? (2012) (31)
Radiobiological rationale and patient selection for high-LET radiation in cancer therapy. (2004) (31)
Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer. (2016) (31)
Importance of Technique, Target Selection, Contouring, Dose Prescription, and Dose-Planning in External Beam Radiation Therapy for Cervical Cancer: Evolution of Practice From EMBRACE-I to II. (2019) (31)
Image guided, adaptive, accelerated, high dose brachytherapy as model for advanced small volume radiotherapy. (2011) (30)
Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE). (2015) (30)
Competencies in radiation oncology: a new approach for education and training of professionals for Radiotherapy and Oncology in Europe. (2012) (29)
Brachytherapy in the combined modality treatment of pediatric malignancies. Principles and preliminary experience with treatment of soft tissue sarcoma (recurrence) and Ewing's sarcoma. (1995) (29)
Risk Factors for Ureteral Stricture After Radiochemotherapy Including Image Guided Adaptive Brachytherapy in Cervical Cancer: Results From the EMBRACE Studies. (2019) (29)
Comparison of imaging accuracy at different MRI units based on phantom measurements. (1995) (29)
Residual tumour volumes and grey zones after external beam radiotherapy (with or without chemotherapy) in cervical cancer patients (2013) (29)
Moderate Dose Escalation in Three-Dimensional Conformal Localized Prostate Cancer Radiotherapy (2009) (28)
Recommendations from gynaecological (GYN) GEC-ESTRO working group - ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancer. (2019) (28)
Feasibility of dominant intraprostatic lesion boosting using advanced photon-, proton- or brachytherapy. (2015) (28)
A detailed dosimetric comparison between manual and inverse plans in HDR intracavitary/interstitial cervical cancer brachytherapy (2010) (28)
Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients. (2016) (27)
Healing of Late Endoscopic Changes in the Rectum between 12 and 65 Months after External Beam Radiotherapy (2011) (26)
Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study. (2018) (26)
Reporting in Brachytherapie: dose and volume specification (2002) (26)
Investigations on Parotid Gland Recovery after IMRT in Head and Neck Tumor Patients (2010) (26)
Management of Nodal Disease in Advanced Cervical Cancer. (2019) (25)
Is mask-based stereotactic head-and-neck fixation as precise as stereotactic head fixation for precision radiotherapy? (2006) (25)
Inverse Planning – a Comparative Intersystem and Interpatient Constraint Study (2006) (25)
Optimizing LINAC-based stereotactic radiotherapy of uveal melanomas: 7 years' clinical experience (2006) (24)
Can treatment of pediatric Hodgkin’s lymphoma be improved by PET imaging and proton therapy? (2012) (24)
Patient Selection for Accelerated Partial Breast Irradiation after Breast-conserving Surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) Breast Cancer Working Group (2010) (24)
Recommendations of the EVA GEC ESTRO Working Group: prescribing, recording, and reporting in endovascular brachytherapy. Quality assurance, equipment, personnel and education (vol 59, pg 339, 2001) (2001) (24)
Vascular brachytherapy with 192Ir after femoropopliteal stent implantation in high-risk patients: twelve-month follow-up results from the Vienna-5 trial. (2005) (24)
Image guided adaptive external beam radiation therapy for cervix cancer: Evaluation of a clinically implemented plan-of-the-day technique. (2017) (24)
Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome. (2019) (23)
Impact of heterogeneity-corrected dose calculation using a grid-based Boltzmann solver on breast and cervix cancer brachytherapy (2016) (23)
Paraneoplastic subacute cerebellar degeneration in Hodgkin's disease Report of three cases and review of the literature (1989) (23)
Incidence of dermatitis in head and neck cancer patients treated with primary radiotherapy and cetuximab (2011) (22)
Determination and application of the reference isodose length (RIL) for commercial endovascular brachytherapy devices. (2002) (22)
Epidemiological aspects of hadron therapy: a prospective nationwide study of the Austrian project MedAustron and the Austrian Society of Radiooncology (OEGRO). (2004) (22)
Increased genitourinary fistula rate after bevacizumab in recurrent cervical cancer patients initially treated with definitive radiochemotherapy and image-guided adaptive brachytherapy (2017) (21)
Impact of organ shape variations on margin concepts for cervix cancer ART. (2016) (21)
Surgery and adjuvant radiation therapy of endometrial stromal sarcoma. (2002) (20)
Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients after Radiochemotherapy with Image-Guided Adaptive Brachytherapy in the EMBRACE I Study. (2020) (20)
Changes in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET (2017) (20)
Image-guided brachytherapy sets benchmarks in advanced radiotherapy. (2009) (20)
Impact of hybrid PET/MR technology on multiparametric imaging and treatment response assessment of cervix cancer. (2017) (20)
Portal imaging based definition of the planning target volume during pelvic irradiation for gynecological malignancies. (1999) (20)
Quality assurance in preoperative radiotherapy of rectal cancer: evaluation of a pre-trial dummy-run. (2000) (20)
Physical and psychosocial support requirements of 1,500 patients starting radiotherapy (2013) (20)
Can reduction of uncertainties in cervix cancer brachytherapy potentially improve clinical outcome? (2016) (20)
Multicenter evaluation of different target volume delineation concepts in pediatric Hodgkin’s lymphoma (2012) (19)
DVH Report on an International Study on MRI-Guided Brachytherapy in Locally Advanced Cervical Cancer (EMBRACE) (2010) (19)
Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study. (2018) (19)
Evidence-Based Dose Planning Aims and Dose Prescription in Image-Guided Brachytherapy Combined With Radiochemotherapy in Locally Advanced Cervical Cancer. (2020) (19)
Fractionated stereotactic radiotherapy with linear accelerator for uveal melanoma — Preliminary vienna results (1999) (19)
Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis. (2021) (19)
Comparison between external beam radiotherapy (70 Gy/74 Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patients. (2012) (18)
Retrospective analysis of re-irradiation in malignant glioma: a single-center experience (2005) (18)
Long-Term Results in Three-Dimensional Conformal Radiotherapy of Localized Prostate Cancer at Moderate Dose (66 Gy) (2006) (17)
Image-guided Adaptive Radiotherapy in Cervical Cancer. (2019) (17)
Paediatric Hodgkin's disease. (1999) (17)
3-D conformal radiotherapy of localized prostate cancer: a subgroup analysis of rectoscopic findings prior to radiotherapy and acute/late rectal side effects. (2006) (17)
Stereotactic Photon Beam Irradiation of Uveal Melanoma: Indications and Experience at the University of Vienna since 1997 (2007) (17)
Concepts for critical organ dosimetry in three-dimensional image-based breast brachytherapy. (2008) (16)
Oxygenation Status of Cervical Carcinomas Before and During Spinal Anesthesia for Application of Brachytherapy (2003) (16)
Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator position. (2015) (15)
New Vienna Applicator Design for Distal Parametrial Disease in Cervical Cancer (2010) (15)
Connection of European particle therapy centers and generation of a common particle database system within the European ULICE-framework (2012) (14)
Evaluation of planning aims and dose prescription in image-guided adaptive brachytherapy and radiochemotherapy for cervical cancer: Vienna clinical experience in 225 patients from 1998 to 2008 (2015) (14)
Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study. (2020) (14)
Long-term side effects of radiotherapy in survivors of childhood cancer. (2002) (14)
Total reference air kerma can accurately predict isodose surface volumes in cervix cancer brachytherapy. A multicenter study. (2017) (14)
Establishing a Global Radiation Oncology Collaboration in Education (GRaCE): Objectives and priorities. (2015) (14)
Late, persistent, substantial, treatment-related symptoms after radiotherapy (LAPERS): A new method for longitudinal analysis of late morbidity - applied in the EMBRACE study. (2020) (14)
11 C-Acetate Positron Emission Tomography Imaging and Image Fusion With Computed Tomography and Magnetic Resonance Imaging in Patients With Recurrent Prostate Cancer (2006) (14)
Possible impact of iridium-192 source centering on restenosis rate after femoro-popliteal angioplasty and endovascular brachytherapy in Vienna-2 study. (2002) (14)
Is the Roach formula predictive for biochemical outcome in prostate cancer patients with minimal residual disease undergoing local radiotherapy after radical prostatectomy? (2010) (14)
Vienna International Summer School on Experimental and Clinical Oncology for Medical Students: An Austrian Cancer Education Project (2010) (13)
The Cyclooxygenase-2 Inhibitor Nimesulide, a Nonsteroidal Analgesic, Decreases the Effect of Radiation Therapy in Head-and-Neck Cancer Cells (2009) (13)
Image-guided Adaptive Brachytherapy for Cervix Cancer - A Story of Successful Collaboration within the GEC-ESTRO GYN Network and the EMBRACE Studies. (2018) (13)
Testicular function in eight patients with seminoma after unilateral orchidectomy and radiotherapy. (1987) (13)
[Planned 3-dimensional low-volume conformal irradiation of a local prostatic carcinoma]. (1997) (13)
External audit on the clinical practice and medical decision-making at the departments of radiotherapy in Budapest and Vienna. (1999) (13)
High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer. (2001) (13)
Adaptive Contouring of the Target Volume and Organs at Risk (2011) (13)
Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis. (2007) (13)
Implementing an online radiotherapy quality assurance programme with supporting continuous medical education - report from the EMBRACE-II evaluation of cervix cancer IMRT contouring. (2020) (13)
Assessment of dose to functional sub-structures in the lower urinary tract in locally advanced cervical cancer radiotherapy. (2019) (13)
Vienna Summer School on Oncology: how to teach clinical decision making in a multidisciplinary environment (2017) (13)
Dose to the non-involved uterine corpus with MRI guided brachytherapy in locally advanced cervical cancer. (2013) (12)
6Radiography compared to sectional image (CT/MR) based 3D treatment planning in cervix cancer brachytherapy: Results of a prospective comparative trial (2001) (12)
Importance of the ICRU Bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: an EMBRACE analysis. (2020) (12)
Information preferences regarding cure rates and prognosis of Austrian patients with advanced lung cancer (2015) (12)
General principles for prescribing, recording and reporting a therapeutic irradiation. (2004) (12)
Image Guided Brachytherapy in Cervical Cancer: A Comparison between Intracavitary and Combined Intracavitary/Interstitial Brachytherapy in Regard to Doses to HR CTV, OARs and Late Morbidity - Early Results from the Embrace Study in 999 Patients (2016) (12)
Clinical quality assurance for endovascular brachytherapy devices. (2004) (11)
Dose-response of critical structures in the posterior eye segment to hypofractioned stereotactic photon radiotherapy of choroidal melanoma. (2013) (11)
Importance of training in external beam treatment planning for locally advanced cervix cancer: Report from the EMBRACE II dummy run. (2019) (11)
OC-88 FIRST CLINICAL RESULTS OF THE GEC-ESTRO BREAST WG PHASE III MULTICENTRIC APBI TRIAL. (2012) (11)
[Metastasizing eccrine porocarcinoma]. (1993) (11)
[Endoluminal HDR brachytherapy in the palliative treatment of patients with the recurrence of a non-small-cell bronchial carcinoma after prior radiotherapy]. (1995) (11)
Evaluation of contouring concepts and dose volume parameters of MR based brachytherapy treatment plans for cervix cancer: results and conclusions of the GEC ESTRO GYN working group delineation workshops (2005) (11)
Biochemical Response after 3-D Conformal Radiotherapy of Localized Prostate Cancer to a Total Dose of 66 Gy (2002) (11)
Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial (2000) (11)
Education and training for image-guided adaptive brachytherapy for cervix cancer-The (GEC)-ESTRO/EMBRACE perspective. (2020) (10)
Subclinical impairment of renal function after radiotherapy for Hodgkin's disease in children. (1993) (10)
Reporting of late morbidity after radiotherapy in large prospective studies: A descriptive review of the current status. (2019) (10)
3-D Conformal radiotherapy of localized prostate cancer within an Austrian–German multicenter trial: a prospective study of patients' acceptance of the rectal balloon during treatment (2006) (10)
Ten years of fast neutron therapy in Münster. (1996) (10)
Individualisation of radiation fields based on modern sectional imaging within combination treatment of pediatric Hodgkin's Disease (HD):Evaluation of 386 patients from the German-Austrian multicentre trial (HD-90) (1995) (10)
Results of fast neutron therapy of adenoid cystic carcinoma of the salivary glands (2009) (10)
Neutron therapy (dT, 14 MeV) for recurrence of rectal cancer: interim analysis from Münster. (1990) (10)
Critical discussion of different dose-volume parameters for rectum and urethra in prostate brachytherapy. (2009) (9)
[A comparison of CT-supported 3D planning with simulator planning in the pelvic irradiation of primary cervical carcinoma]. (1999) (9)
MRI-based contouring of functional sub-structures of the lower urinary tract in gynaecological radiotherapy. (2020) (9)
Beta endovascular brachytherapy using CO2-filled centering catheter for treatment of recurrent superficial femoropopliteal artery disease. (2009) (9)
Dose planning variations related to delineation variations in MRI-guided brachytherapy for locally advanced cervical cancer. (2020) (9)
Distant Metastases in Locally Advanced Cervical Cancer Pattern of Relapse and Prognostic Factors: Early Results From the EMBRACE Study (2015) (9)
Use of neutron therapy in the management of locally advanced nonresectable primary or recurrent rectal cancer. (1998) (9)
Present Status of Endovascular Brachytherapy in Peripheral Arteries (2002) (9)
Abdominal irradiation in unilateral nephroblastoma and its impact on local control and survival. (1998) (9)
The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy (2019) (8)
OC-0055: Local failures after radiochemotherapy and MR-image-guided brachytherapy in cervical cancer patients (2017) (8)
Nodal Failure After Chemoradiation and Magnetic Resonance Imaging Guided Adaptive BT in Cervical Cancer: A Subanalysis Within Embrace (2016) (8)
Impact of vaginal symptoms and hormonal replacement therapy on sexual outcomes in locally advanced cervical cancer patients after definitive chemoradiotherapy - results from the EMBRACE-I study. (2021) (8)
Long-term results of the German-Austrian phase II study – accelerated partial breast irradiation using multicatheter brachytherapy for early breast cancer (2009) (8)
Austrian Breast Cancer Patterns-of-Care Studies PCS93 and PCS01 versus PCS85 to Identify Changes in National Practice (2007) (8)
Endovascular brachytherapy in peripheral arteries. (2003) (8)
Radiotherapy in lymph node-positive prostate cancer patients - a potential cure? Single institutional experience regarding outcome and side effects. (2008) (7)
[Isolated vaginal recurrences in endometrial carcinoma: treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy]. (1998) (7)
Neutron radiotherapy in adenoidcystic carcinoma: preliminary experience at the Münster neutron facility. (1990) (7)
Improved source path localisation in ring applicators and the clinical impact for gynecological brachytherapy (2015) (7)
Treatment of vascular soft tissue sarcomas with razoxane, vindesine, and radiation. (2009) (7)
Hyperfractionated accelerated radiochemotherapy (HFA-RCT) with mitomycin C for advanced head and neck cancer. (2004) (7)
[Radiotherapy of follicle center lymphoma. Results of a German multicenter and prospective study. Members of the Study Group "NHL-early stages"]. (1998) (7)
Preliminary Results of a Comparison between High-tech External Beam and High-tech Brachytherapy for Cervix Carcinoma (2007) (7)
OC-0265: Dose-response for local control in image guided cervix brachytherapy in the retroEMBRACE study (2013) (6)
4CT-based treatment planning in cervix carcioma — dose reduction to the rectum and its impact on the dose to the CTV: A retrospective analysis (2001) (6)
Persistence of late substantial patient-reported symptoms (LAPERS) after radiochemotherapy including image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study. (2020) (6)
Union of light ion therapy centers in Europe (ULICE EC FP7) - Objectives and achievements of joint research activities. (2018) (6)
Comprar Gynecologic Radiation Therapy. Novel Approaches To Image-Guidance And Management | A. N. Viswanathan | 9783540689546 | Springer (2010) (6)
Estimation of doses to personnel and patients during endovascular brachytherapy applications. (2004) (6)
53 speaker RETRO-EMBRACE: PRELIMINARY RESULTS OF IMAGE GUIDED BT FOR CERVICAL CANCER IN THE LAST YEARS OF THE 20ST CENTURY (2011) (6)
54 speaker EMBRACE UPDATE (2011) (6)
[Analysis of different application systems and CT-controlled planning variants in treatment of primary endometrial carcinomas. Is brachytherapy treatment of the entire uterus technically possible?]. (1998) (6)
Intercomparison of treatment concepts for 3D image guided brachytherapy of cervical carcinoma based on a GEC-ESTRO study protocol (2004) (5)
NORMAL TISSUE REACTIONS IN RADIOTHERAPY AND ONCOLOGY (2002) (5)
[MRI-assisted brachytherapy of nonresectable liver metastases. Preliminary technical and clinical experiences]. (2001) (5)
Three dimensional conformal photon radiotherapy at a moderate dose level of 66 Gy for prostate carcinoma: Early results (1999) (5)
High-tech image-guided therapy versus low-tech, simple, cheap gynecologic brachytherapy. (2015) (5)
Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer (2020) (5)
Validation and practical implementation of a multidisciplinary cancer distress screening questionnaire (2013) (5)
151 oral ANALYSIS OF SPATIAL AGREEMENT BETWEEN CT (+PREBT MRI) AND MRI BASED HRCTV DELINEATION IN CERVIX CANCER BRACHYTHERAPY (2011) (5)
Risk factors for nodal failure after radiochemotherapy and image-guided brachytherapy in locally advanced cervical cancer: an EMBRACE analysis. (2021) (5)
Postoperative radiotherapy for prostate cancer (2017) (5)
Dose and Volume Response for Local Control in Locally Advanced Cervical Cancer Treated With EBRT Combined With MRI-Guided Adaptive Brachytherapy (2014) (5)
Neoadjuvant Hormonal Treatment and Radiotherapy for Prostate Cancer (2003) (5)
Vascular morphometric changes after radioactive stent implantation: a dose-response analysis. (2002) (5)
Treatment results of fast neutron irradiation in soft tissue sarcomas (1999) (4)
[Representation and transfer of labeled reference structures in X-ray, CT and MR imaging]. (1995) (4)
Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer (2018) (4)
Endovascular brachytherapy: effect on acute inflammatory response after percutaneous femoropopliteal arterial interventions. (2004) (4)
Early morbidity and dose–volume effects in definitive radiochemotherapy for locally advanced cervical cancer: a prospective cohort study covering modern treatment techniques (2021) (4)
Treatment parameters for beta and gamma devices in peripheral endovascular brachytherapy. (2004) (4)
Paediatric Malignancies (2003) (4)
Patterns of care in radiotherapy of breast cancer in Austria 1985: data acquisition and comparison with data of US-PCS 1983. (2004) (4)
Randomized blinded clinical trial of intracoronary brachytherapy with 90Sr/Y beta-radiation for the prevention of restenosis after stent implantation in native coronary arteries in diabetic patients. (2006) (4)
OC-0052: Physician assessed and patient reported bladder morbidity after RCHT and IGABT for cervical cancer (2017) (4)
Clinical Aspects of Treatment Planning (2011) (4)
Importance of Technique, Dose Prescription, and Contouring in Cervix External Beam Radiation Therapy: Current and Future Practice in a Large Multicenter Study (EMBRACE) (2016) (4)
Digital subtraction angiography (IV DSA) in treatment planning of subdiaphragmatic Hodgkin's disease. (1989) (4)
SU‐GG‐T‐02: Inverse Optimization for Cervix Cancer Brachytherapy Including Automatic Loading, DVH Optimization and Modification Restriction Adapted From Manual Planning (2008) (4)
[Mediastinal Hodgkin lymphomas in computerized tomography. Comparison of exact CT-assisted volumetry and volume assessment using simple geometric models]. (2001) (4)
OC-0392: Impact of image-guided brachytherapy on pattern of relapse in the RetroEMBRACE cervical cancer study (2018) (4)
73 : The Predictive Value of Dose Volume Parameters in MRI Based Cervical Cancer Brachytherapy for Late Adverse Side Effects in Rectum, Sigmoid and Bladder (2006) (4)
Inflatable multichannel rectal applicator for adaptive image-guided endoluminal high-dose-rate rectal brachytherapy: design, dosimetric characteristics, and first clinical experiences (2017) (4)
Treatment planning and delivery in neutron radiotherapy of soft tissue sarcomas. (1990) (4)
Severity and persistency of late gastrointestinal morbidity in locally advanced cervical cancer: lessons learned from EMBRACE-I and implications for the future. (2021) (4)
[Multi-national therapy study for Hodgkin's disease in children and adolescents GPOH-DH 95. Interim report after 2 1/2 years]. (1998) (4)
Dose-volume histograms based on serial intravascular ultrasound: a calculation model for radioactive stents. (2001) (3)
[The results of primary HDR-afterloading brachytherapy in corpus carcinoma]. (1995) (3)
8HDR-brachytherapy boost for T1/T2-breast cancer-first results of a longterm follow up (1998) (3)
3D MRI-based brachytherapy for cervical cancer (2008) (3)
[OA039] Contouring and dose reporting for lower urinary tract sub-structures in cervix cancer (2018) (3)
Descriptive Analysis of Bladder Morbidity after Definitive Radiotherapy (±Chemotherapy) and Image Guided Adaptive Brachytherapy (IGABT) for Locally Advanced Cervical Cancer. A Report from the EMBRACE Study (2016) (3)
SP-0126: Dose response and dose effect of IGABT in cervix cancer (2015) (3)
3D-conformal radiotherapy for prevention of carotid recurrent in-stent restenosis: Initial experience (2005) (3)
Technique of Magnetic Resonance Imaging Assisted Simulation Based on Direct Coronal Imaging for Treatment Planning of Supradiaphragmatic Malignant Lymphoma (1992) (3)
Results of Image guided brachytherapy for stage IB cervical cancer in the RetroEMBRACE study. (2021) (3)
Phase III Multicenter Trial: Interstitial Brachytherapy Alone Versus External Beam Radiation Therapy after Breast Conserving Surgery for Low-Risk Invasive Carcinoma and Low-Risk Ductal Carcinoma In-Situ of the Female Breast – One-Year Toxicities (2013) (3)
89 poster: Concept, Feasibility and Results of Vaginal Dose Mapping for Different Brachytherapy Treatment Techniques and Dose Rates for Cervical Cancer Patients (2009) (3)
Initiatives for education, training, and dissemination of morbidity assessment and reporting in a multiinstitutional international context: Insights from the EMBRACE studies on cervical cancer. (2020) (3)
The Münster Experience with Magnetic Resonance Imaging Assisted Treatment Planning Used for High Dose Rate Afterloading Therapy of Gynecological and Nasopharyngeal Cancer (1992) (3)
Treatment of locally advanced vaginal cancer with radio-chemotherapy and MRI-guided brachytherapy: Clinical feasibility and first results (2009) (2)
Loading pattern calculated by inverse optimization vs traditional dosimetry systems of intracavitary brachytherapy of cervical cancer – A dosimetric study (2009) (2)
[Dosimetry methods in determining radiation dosage of the rectum in HDR-brachytherapy of cervix carcinoma]. (1998) (2)
[Preoperative chemotherapy of nephroblastoma. Preliminary results of the SIOP-9/GPO therapy study]. (1992) (2)
Reporting time-dose pattern in intra-cavitary brachytherapy. Considerations on a common language using the linear quadratic model (2004) (2)
1504 poster EVALUATION OF THE REPRODUCIBILITY OF PATIENT SETUP FOR A DOUBLE-MASK SYSTEM USING ADDITIONAL THERMOPLASTIC PELLES FOR PRECISION RADIOTHERAPY (2011) (2)
Early ultrasonographic tumor regression after linear accelerator stereotactic fractionated photon radiotherapy of choroidal melanoma as a predictor for metastatic spread. (2018) (2)
Impact of Magnetic Resonance Imaging Assisted Simulation on Target, Treatment, and Irradiation Volume in Treatment Planning of Prostate Cancer (1992) (2)
OC-0087: Correlation of dose with vaginal morbidity after MRI-guided brachytherapy for locally advanced cervical cancer (2013) (2)
A challenge for high-precision radiation therapy: The case for hadrons (2009) (2)
OC-83 SPATIAL DOSIMETRIC SENSITIVITY ANALYSIS OF CONTOURING UNCERTAINTIES IN GYN 3D-BASED BRACHYTHERAPY (2012) (2)
Attitude Towards End of Life Communication of Austrian Medical Students (2019) (2)
Side-effects after combination therapy for Ewing's sarcoma. (1993) (2)
Assessment of Tumor Remission Based on Imaging Data (One-, Two-, Three-Dimensional) in Adenoid-Cystic Carcinoma of the Minor Salivary Glands After Neutron Radiotherapy (1992) (2)
Incidences of Late Toxicities and Cosmetic Results after Accelerated Partial Breast Irradiation with Multi-Catheter Brachytherapy or Whole Breast Irradiation: 5-Year Results of the GEC-ESTRO Phase III APBI Trial (2016) (2)
109 UPCOMING ICRU/GEC ESTRO RECOMMENDATIONS FOR BRACHYTHERAPY IN CANCER OF THE CERVIX (2) (2012) (2)
Vienna experience in 145 cervical cancer patients treated by systematic MRI-based intracavitary ± interstitial brachytherapy from 1998-2003: Impact on local control (2006) (2)
ÖGRO survey on radiotherapy capacity in Austria (2018) (2)
Magentic Resonance Imaging Assisted Localization of Tumor and Applicator for Brachytherapy of Cancer of the Esophagus (1992) (2)
PO-0940: 3D mapping for precise definition of GTV, CTV and their correlation in cervix cancer BT (EMBRACE) (2017) (2)
Bowel Morbidity in Locally Advanced Cervical Cancer Patients Treated with Combined External Beam Radiotherapy, Image-Guided Adaptive Brachytherapy (IGABT) and Concomitant Chemotherapy; a Descriptive Analysis from the Embrace Study (2016) (2)
OC-43 TREATMENT DOSE AND VOLUME PARAMETERS FROM 3 YEARS EXPERIENCE OF THE EMBRACE STUDY (2012) (2)
Endovascular Brachytherapy (2003) (2)
Concepts and terms for dose/volume parameters in carbon-ion radiotherapy: Conclusions of the ULICE taskforce. (2018) (2)
67 Intraarterial 192Ir HDR BT for prophylaxis of restenosis after femoropopliteal transluminal angioplasty; prospective; randomized trial-Vienna 2; results after 6 months minimum follow-up; risk factor analysis (1999) (2)
OC-0056: Bowel morbidity in cervix cancer after RCHT+IGABT; physician and patient reported outcome - EMBRACE (2017) (2)
Late side effects of pediatric radiotherapy. (1993) (2)
Dissolution Glow Curve in LLD (1990) (2)
Pre-Implant Clinical and Radiological MRI Assessment Improves CT-Based HRCTV Delineation in Cervical Cancer Patients (2011) (2)
OC-0263: Brachytherapy vaginal dose de-escalation in locally advanced cervical cancer (2014) (2)
Commissioning of a micro-multileaf collimator. (1999) (2)
SP-0304: The contribution of the ULICE project to the development of hadron therapy in Europe (2015) (2)
[The radiotherapy of hyperplastic heterotopic ossification in osteogenesis imperfecta. 2 case reports]. (1994) (2)
A Volumetric Analysis of GTVD and HR CTV as Defined by the GEC ESTRO Recommendations in FIGO Stage IIB Cervical Cancer Patients Treated With IGABT in a Prospective Multicentric Trial (2014) (2)
Hadrontherapy with carbon12: radiotherapy of the near future. (2004) (2)
51 oral: MRI-Guided BT With Ebrt Plus Chemotherapy for the Treatment of Locally Advanced Vaginal Cancer (2009) (2)
PO-0809: Implementing a novel online education programme to support RTQA – the EMBRACE-II experience (2018) (2)
1 Quality assurance in HDR-brachytherapy of carcinoma of the cervix (1994) (1)
Accelerated Partial Breast Irradiation (APBI) Using Sole Interstitial Multicatheter Brachytherapy - GEC-ESTRO Phase III Non-Inferiority Trial: Subanalysis of 5-Year Results Reflecting Current GEC-ESTRO and ASTRO Recommendations for Patient Selection (2016) (1)
Long term results of pulse dose rate brachytherapy for repeat irradiation in locally recurrent breast cancer (2007) (1)
43 HDR- brachytherapy with or without external beam radiotherapy in the treatment of primary vaginal carcinoma: Results and side effects (2000) (1)
Comparison of coplanar and non-coplanar irradiation techniques for malignant glioma: an analysis of dose-volume histograms. (1999) (1)
The Vienna experience with primary and adjuvant irradiation of sarcoma of the corpus uteri (1997) (1)
[Permanent interstitial brachytherapy (seeds) for patients with primary localized prostate cancer: analysis of 100 patients]. (2007) (1)
350Combined modallity treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas (1996) (1)
[The sensitivity of computed tomography in the detection of malignant melanomas of the choroid]. (1991) (1)
Correction to: Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer (2018) (1)
Basic treatment planning parameters for a 90Sr / 90Y source train used in endovascular brachytherapy. (2004) (1)
OC-0073: Isodose surface volume in cervix brachytherapy: dependence on image guided adaptation and applicator (2018) (1)
[Treatment results of surgical and radiologic therapy of penile cancer]. (1988) (1)
SP-0625: ICRU GEC ESTRO report on image guide adaptive brachytherapy in cancer of the cervix (IGABT) (2013) (1)
Bronchus Cancer (2003) (1)
OC-0391: Evolution of external beam radiotherapy in cervix cancer: from EMBRACE I to EMBRACE II (2018) (1)
OC-0360: Impact of random dosimetric uncertainties on dose-response curves for HDR cervix cancer brachytherapy (2013) (1)
[Results of the treatment with fast neutrons (d.T 13 MeV) in recurrent rectal carcinoma]. (1997) (1)
Accelerated Partial Breast Irradiation With Multi-Catheter Brachytherapy: Local Control, Side Effects and Cosmetic Outcome for 274 Patients. Results of the German-Austrian Multi-centre Trial (2007) (1)
In Reply to Dr. Cengiz et al. (2007) (1)
343 Is there room for respiration controlled delivery in stereotactic body radiotherapy (2005) (1)
Application of GEC-ESTRO recommendations on reporting 3D image based cervix cancer brachytherapy - Intercomparison of MR based treatment approaches in 3 different institutions (2004) (1)
554 speaker CERVIX CANCER: IMAGE GUIDED ADAPTIVE BRACHYTHERAPY IN THE SETTING OF DEFINITIVE RADIO-CHEMOTHERAPY – STATUS OF CURRENT MULTI-CENTRE STUDIES (2011) (1)
382 oral COMPARISON OF DVH-PARAMETERS FOR DOSE CALCULATION BY TG43 AND BOLTZMANN BASED ALGORITHM ACUROS BV(tm) (2011) (1)
OC-0051: Fatigue, insomnia, hot flashes (CTCAE) after definitive RCHT+IGABT for cervical cancer (EMBRACE) (2017) (1)
PD-0213 RETRO-EMBRACE: A MULTICENTRE RETROSPECTIVE STUDY OF IMAGE GUIDED ADAPTIVE BRACHYTHERAPY IN CERVICAL CANCER (2012) (1)
[Radiotherapy of penis and urethral cancers]. (1986) (1)
Systematic comparison of two methods of bladder contouring in cervix cancer brachytherapy: “Direct” vs. “indirect” (2009) (1)
Experience in LLD During Low and High LET Radiotherapy (1990) (1)
Reproducibility of irregular radiation fields for malignant lymphoma (1998) (1)
3D-conformal radiotherapy for inoperable non-small-cell lung cancer - A single centre experience (2007) (1)
Organization of the multidisciplinary daily practice of endovascular brachytherapy: the view of the EVA GEC ESTRO working group (2002) (1)
646 poster IMPACT OF INFORMATION FROM FIGO STAGE +/− 3D CLINICAL DRAWING ON HRCTV DELINEATION FOR CT BASED CERVICAL CANCER BRACHYTHERAPY WITH STANDARDIZED LENGTHS (2011) (1)
344 Impact of a feedback system on a precise gated breath hold technique during SBRT (2005) (1)
[Monitor assessment of digitalized and post-processed portal films compared to conventional films presented on a light box]. (1998) (1)
Experience with High-Dose β-Irradiation ( 106 Ru/ 106 Rh) of Choroidal Melanomas (1991) (1)
107 MULTICENTER STUDIES WITH IMAGE GUIDED BRACHYTHERAPY IN CERVICAL CANCER (2012) (1)
Connection of European particle therapy centers and generation of a common particle database system within the European ULICE-framework (2012) (1)
The role of radiotherapy in the management of Hodgkin disease in childhood — results of the German association for treatment and research in pediatric leukaemia (DAL) (1989) (1)
18 Long-term results of adjuvant irradiation of endometrial carcinoma stage 1 with two different treatment schedules (2001) (1)
Breast conserving surgery and PDR-Brachytherapy for recurrent breast cancer after primary breast conserving treatment Including EBT and HDR-Brachytherapy — Preliminary results (1997) (1)
718Factors predicting for late rectal morbidity after 3-D-planned radiotherapy of localized prostate cancer (1996) (1)
Treatment planning in subdiaphragmatic Hodgkin's disease by digital subtraction angiography (IV DSA) (1987) (1)
Exclusive 3D-brachytherapy as a good option for stage-I inoperable endometrial cancer: a retrospective analysis in the gynaecological cancer GEC-ESTRO Working Group (2021) (1)
47 Results of hdr-brachytherapy combined with external beam therapy in the primary treatment of cervical carcinoma (2000) (1)
OC-0481: Late toxicity and cosmesis after APBI with brachytherapy vs WBI: 5-year results of a phase III trial (2016) (1)
[Nasopharyngeal involvement in Hodgkin's disease--its diagnosis by CT and MRT. A case report]. (1990) (1)
Patient-reported sexual frequency and vaginal functioning in patients with locally advanced cervical cancer following definitive radiochemotherapy and image-guided adaptive brachytherapy (EMBRACE study) (2019) (1)
Stage adapted combination therapy with OPPA (or OEPA)/COPP chemotherapy and low- dose radiotherapy in children and adolescents with Hodgkin's disease. Results of the German/Austrian Pediatric Therapy Study DAL-HD-90 in 578 patients (1998) (1)
190 speaker PUBLICATIONS OF BRACHYTHERAPY ARTICLES: OVERVIEW AND CURRENT TRENDS WITH FOCUS ON “RADIOTHERAPY AND ONCOLOGY” (2011) (1)
Radiation Therapy of Invasive Breast Cancer (2006) (1)
OC-0053: Physician assessed and patient reported limb edema after RCHT+ IGABT for cervical cancer (EMBRACE) (2017) (1)
54 oral: Frequency-Distribution Mapping of HR-CTV in Locally Advanced Cervix Cancer: A New Tool for Development of Novel Brachytherapy Techniques (2009) (1)
18 Late persistant substantial patient reported symptoms (LAPERS), after radio(CHEMO)therapy and MRI image-guided adaptive brachytherapy for locally advanced cervical cancer in the embrace study (2019) (1)
[Partial breast irradiation for early breast cancer with favorable prognostic factors: 3-year results of the German-Austrian phase II-trial]. (2005) (1)
OC-0317: Risk factors for persistent late fatigue after radiochemotherapy in cervical cancer (EMBRACE study) (2020) (1)
LOADING PATTERNS USED DURING 10 YEARS FOR MRI BASED TREATMENT PLAN OPTIMIZATION OF 254 CERVICAL CANCER BRACHYTHERAPY PATIENTS (2009) (0)
SP-0128: Patient reported quality of life with IGABT in cervical cancer (2015) (0)
Brachytherapy of cervical cancer Clinical outcome of protocol based image ( MRI ) guided adaptive brachytherapy combined with 3 D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer (2011) (0)
92 poster: Endoscopy for PRospective Longitudinal 3D Assessment of Vaginal Morbidity: Method and Feasibility (2009) (0)
Transrectal Ultrasound for Cervix Cancer Brachytherapy: Combining Ultrasound-Based Target Definition and CT-Based Treatment Planning (2016) (0)
776Comparison of different measurement systems used for data acquisition of a stereotactic system (1996) (0)
PART II: CLINICAL PRACTICE 28 Bile Duct Cancer (2017) (0)
15 Endometrial Cancer (2003) (0)
628Results of combined HDR-rrachytherapy and external beam therapy in patients with high risk endometrial carcinoma (1996) (0)
Quality assurance in mri assisted treatment planning: comparison of imaging accuracy at different mri units based on phantom measurements (1993) (0)
88 Intraarterial hdr brachytherapy after femoro-popliteal PTA + stent implantation. Pilot study vienna-4 (2000) (0)
2137 Results of fast neutron therapy of adenoid cystic carcinoma of the salivary glands (1997) (0)
A step towards international prospective trials in carbon ion radiotherapy: investigation of factors influencing dose distribution in the facilities in operation based on a case of skull base chordoma (2019) (0)
PO-1015: Image-guided salvage radiotherapy of pelvic recurrences in post-hysterectomy endometrial cancer (2018) (0)
Radiation Therapy of Benign Diseases. S.E. Order, S.S. Donaldson. A Clinical Guide. Edited by L.W. Brady, H.-P. Heilman, Medical Radiology, Radiation Oncology. 2nd Revised Edition, Springer, Berlin, 1998 (2000) (0)
Results of combined HDR-brachytherapy and external beam therapy in patients with high risk endometrial carcinoma (1997) (0)
The current place of radiation therapy in cervical cancer – Focus on image-based brachytherapy (2007) (0)
OC-0486: Nodal failure after (chemo-)radiation and MRI guided adaptive BT in cervical cancer: a sub-analysis within EMBRACE (2015) (0)
OC-0276: Comparison of MRI, TRUS and CT for target definition in image-guided adaptive brachytherapy of cervical cancer (2015) (0)
24 Oesophageal Cancer (2003) (0)
PS-02-013 Vaginal stenosis after definitive radio(chemo)therapy in locally advanced cervical cancer patients: Morphological appearance and length reduction (2016) (0)
EP-1790: A balloon applicator with adjustable catheters for image-guided endoluminal rectal brachytherapy (2017) (0)
212The Vienna experience in primary treatment of endometrial carcinoma with HDR-brachytherapy (1996) (0)
[Threshold contrast and the x-ray film]. (1988) (0)
Target determination in cervical cancer brachytherapy (2004) (0)
[Evaluation of the effectiveness of radiotherapy in an Austrian-Hungarian collaboration]. (1999) (0)
Surgical oncology from a radio-oncological perspective (2006) (0)
CBCT-BASED VOLUME DEFINITION: BENCHMARKED INTER-OBSERVER VARIABILITY AND THE IMPACT ON ADAPTIVE RADIOTHERAPY (2009) (0)
Experience with Digital Subtraction Angiography in Treatment Planning of Subdiaphragmatic Malignant Lymphoma (1992) (0)
[Therapeutic results after irradiation of advanced hypopharyngeal cancer]. (1987) (0)
Individually modified involved field technique of the German/Austrian Pediatric Hodgkin Study (HD90): A way to reduce treatment volume without increase of relaps (1997) (0)
SP-0122: Radiotherapy perspective in locally advanced disease (2018) (0)
Magnetic Resonance Imaging Based Simulation for Neutron Radiotherapy in Minor Salivary Gland Cylindromas: Primary Experience at Münster University (1992) (0)
EP-1268: Biological treatment response and hypoxia monitoring of cervix cancer using multiparametric 3T-MRI and 18F-FMISO (2015) (0)
OC-44 MODELS FOR BRACHYTHERAPY DOSE DE-ESCALATION IN LOW RISK LOCALLY ADVANCED CERVICAL CANCER PATIENTS (2012) (0)
Comparison of acute and late toxicity among head and neck cancer patients treated with primary, adjuvant and neoadjuvant imrt bythree independent methods (2007) (0)
SP-0103: Morphological adaptation in cervix cancer (2015) (0)
A Simple Optimization System to Reduce Rectal Dose During HDR Brachytherapy for Cervix Cancer (2005) (0)
Assessment of Parametrial Response by Growth Pattern in Patients With FIGO Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective Multicentric Trial (EMBRACE) (2015) (0)
SP-0195: From technical and conceptual innovation to physics and clinical evidence - the evolution of image guided radiotherapy in cervical cancer (2020) (0)
Analysis of standard loading patterns for cervix brachytherapy using MRI-based dosimetry (2009) (0)
In reply A. Sharma et al. (2013) (0)
Irradiated Volumes in Image Guided Adaptive Brachytherapy in Cervix Cancer: Results from the EMBRACE Study (2017) (0)
Efficacy of standard treatment in patients with Hodgkin's disease--a single center experience. (2000) (0)
SP-0486: Adaptive planning, dose delivery and verification with MRI based brachytherapy (2016) (0)
PV-0252: Image-guided boost brachytherapy for anal canal cancer: tumour and functional outcome (2018) (0)
312Radiotherapy in the combined treatment of localised not highly chemosensitive soft tissue sarcomas in children. Experience of the German Cooperative Soft Tissue Sarcoma study group in 161 patients (1996) (0)
[Quality assurance in the microfilming of x-ray pictures]. (1989) (0)
590Treatment results in 65 patients with brain metastasis from lung adenocarcinoma after radiosurgery alone (gamma knife) or combination treatment with additional fractionated external beam therapy (1996) (0)
SP-0616 ULICE – UNION OF LIGHT ION CENTRES IN EUROPE (2012) (0)
Erratum to : ‘Recommendations of the EVA GEC ESTRO Working Group: prescribing, recording, and reporting in endovascular brachytherapy. Quality assurance, equipment, personnel and education’[Radiother. Oncol. 59 (2001) 339-360] (2001) (0)
Applicability of LLD in neutron dosimetry. (1990) (0)
Electronic Poster: Brachytherapy track: GynaecologyEP-1601: Impact of dose constraints on local control and G4 toxicity in image-guided adaptive brachytherapy for cervix cancer (2015) (0)
HDR-brachytherapy is an effective treatment modality in primary treatment of inoperable patients with endometrial carcinoma (1997) (0)
Planning target volume and dose prescription in definitive radiotherapy for prostate cancer with favourable prognostic factors. (2002) (0)
54 Possible impact of 192-IR endovascular brachytherapy source centering on the restenosis rate in vienna-2 study (2000) (0)
Brachytherapy for Oesophageal Cancer (2002) (0)
A Prospective Interobserver Study for Hybrid TRUS/CT Target Volume Contouring for Image-guided Brachytherapy of Cervical Cancer (2018) (0)
466 A treatment planning comparison of conventional, 3D conformal, intensity modulated photon — and proton irradiation therapy in the treatment of paranasal sinus carcinoma (2003) (0)
91. Functional sub-structures of lower urinary tract in cervix cancer: Contouring and dose distribution (2018) (0)
Learning curve experience in LDR prostate brachytherapy (2012) (0)
PO-271 TRANSRECTAL ULTRASOUND FOR THE ASSESSMENT OF CERVIX CANCER IN THE COURSE OF PRIMARY RADIOCH EMOTHERAPY (2012) (0)
EP-1301: Early toxicity for image guided adaptive radiochemotherapy including brachytherapy in cervix cancer (2017) (0)
177 O - A prospective randomized trial on neoadjuvant and adjuvant chemo- and radiotherapy in primarily inoperable soft tissue sarcoma (1996) (0)
Why Particle Therapy Rather than Photon Therapy or How to Integrate the Decision into Multimodal Management (2018) (0)
PV-0257: Functional sub-structures of lower urinary tract in cervix cancer: contouring and dose distribution (2018) (0)
Stereotactic irradiation of uveal melanoma at a 6 MV-linear accelerator — Technical considerations concerning movement verification by video recording (1999) (0)
Pulsed dose rate brachytherapy in the treatment of head and neck carcinoma (1999) (0)
[Neutron therapy for adenoid cystic carcinoma]. (1990) (0)
70 Primary treatment of endometrial carcinoma with HDR-brachytherapy: Results of 12 years of experience with 280 patients (1995) (0)
PV-0260: On the implementation of IGBT for cervix cancer in the observational multicenter study EMBRACE (2018) (0)
OC-0405 REPORTING OF LATE RECTAL AND URINARY BLADDER SIDE EFFECTS AFTER MRI GUIDED ADAPTIVE BRACHYTHERAPY OF CERVIX CANCER (2012) (0)
Lyoluminescence in Neutron Therapy (1988) (0)
In response to the letter to the editor from Sylvia van Dyk et al. regarding our editorial "High-tech image-guided therapy vs. low-tech, simple, cheap gynecologic brachytherapy". (2016) (0)
288Quality assurance of stereotactic treatment (1996) (0)
OC-0105: Combined IC/IS BT does not increase late morbidity compared with IC BT in IGABT for locally advanced cervical cancer (2015) (0)
Morbidity Related to the Use of 3D-Based External Beam Radiation and Image-Guided Brachytherapy (2011) (0)
In response to Dr. Narayan et al (2005) (0)
In reply to Whitley et al. (2014) (0)
Results of the German-Austrian multicentre study for 3D-CRT of localised prostate cancer with 70/74 Gy in a follow-up to 7 years: Biochemical and clinical controls, acute and late toxicity (2007) (0)
OC-0396: Late, persistent, substantial and treatment related symptoms (LAPERS): a new metric for late effects (2018) (0)
PO-0756: Total dose to sites of nodal failure in cervical cancer patients: A sub study in EMBRACE (2014) (0)
546Comparison of patient self-report of symptoms to medical professional report during 3-D-planned radiotherapy of prostate cancer (1996) (0)
PO-1016: TRUS/CT for IGABT in cervical cancer: an interobserver study on target volume contouring (2018) (0)
Response to yuce sari et al. (2021) (0)
OC-0105: Hybrid F-MISO PET/MRI for radiation therapy response assessment in cervix cancer (2017) (0)
693 poster MANUAL AND AUTOMATIC TREATMENT PLANNIG IMAGE-GUIDED CERVICAL CANCER BRACHYTHERAPY TRETMENT PLANS (2011) (0)
78 oral: Dummy Run as a QA Tool in the Embrace Study (2009) (0)
Brachytherapy for Bronchus Cancer (2002) (0)
340Influence on image quality in portal imaging by systematic image processing — An interobserver analysis (1996) (0)
Atherosclerotic plaque and dose attenuation of different vascular brachytherapy sources: An ex vivo dosimetry study (2003) (0)
Austria: Medical University of Vienna, Vienna (2011) (0)
PO-0753: Molecular imaging of tumour microenvironment in cervix cancer with multiparametric 3T-MRI and 18F-FMISO-PET/CT (2014) (0)
Partial breast irradiation with 192-iridium implants after breast conserving surgery: Perioperative morbidity, toxicity and cosmetic outcome (2004) (0)
174 Intensity modulated radiotherapy for gynaecological malignancies (2005) (0)
31. Endovascular brachytherapy (2001) (0)
Reply to the Letter to the Editor by H. Yamazaki et al. (2017) (0)
30 Uveal Melanoma (2003) (0)
Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial (2012) (0)
Assessment of Bladder Dose Location in MRI Guided Adaptive Cervical Cancer Brachytherapy (2011) (0)
PO-0757 PET IMAGING AND PROTONS POTENTIALLY IMPROVE RADIOTHERAPY OF PAEDIATRIC HODGKIN PATIENTS (2012) (0)
SP-0504: Impact of geometrical uncertainties in extreme hypo with brachytherapy (2015) (0)
178 P - A randomized trial of adjuvant treatment of soft tissue sarcomas by either radiotherapy or radiotherapy + ifosfamide, adriblastin and DTIC (IFADIC) intensified by the use of G-CSF (1996) (0)
33 Endovascular HDR-brachythempy for prophylaxis of restenosis after femoropopliteal PTA; preliminary results from a randomised trial (1998) (0)
Clinical Results of Image Guided Brachytherapy and Concurrent Radiochemotherapy in Locally Advanced Cervical Cancer: A Report from RetroEMBRACE (2016) (0)
OC-81 A MULTICENTRE COMPARISON OF INTER- AND INTRA-FRACTIONAL ORGAN MOVEMENT IN CERVIX CANCER BT AND ITS DOSIMETRIC IMPACT (2012) (0)
23 WHAT ARE THE PITFALLS (INTEGRATING ORGAN MOTION, EXTERNAL BEAM) (2012) (0)
Three-dimensional Image-based Adaptive Cervical Cancer Brachytherapy (0)
Modern radiotherapy (RT) for medical oncologists and surgeons (1999) (0)
Stage Migration between Clinical Examination and MRI in Locally Advanced Cervical Cancer (2019) (0)
Outcomes Related to the Disease and the Use of 3D-Based External Beam Radiation and Image-Guided Brachytherapy (2011) (0)
SP-0198: ICRU guidelines for gynaecological brachytherapy (2014) (0)
Results of visually-supported adaptive brachytherapy (IGABT) on locally advanced cervical cancer (2014) (0)
PO-0732: Postoperative radiotherapy for prostate cancer: Morbidity due to local vs. pelvic radiotherapy (2014) (0)
OC-0524: Image guided adaptive radiotherapy - the paradigm of cervix cancer brachytherapy (2014) (0)
66 Results of primary and postoperative irradiation of sarcoma of the corpus uteri (1996) (0)
783The first Austrian clinical portal imaging devide. A new approach to determine the image-quality parameters of portal imaging systems. Experiences in physical and clinical application (1996) (0)
PD-0605: Nodal failure in cervix cancer treated with (chemo-) radiation and MRI guided brachytherapy: a substudy in EMBRACE (2013) (0)
Experience with Magnetic Resonance Imaging Assisted Simulation (Integrating Sagittal and Coronal Imaging) in Tumors of the Head: A First Step to Conformation Radiotherapy (1992) (0)
282Nephroblastoma: Role of radiotherapy within the frame of the SIOP/GPOH experience (1996) (0)
52 Neutron therapy in adenoid cystic cancer of the salivary glands (1996) (0)
269 speaker ULICE -UNION OF LIGHT – ION CENTRES IN EUROPE: WORKING FOR HADRONTHERAPY (2011) (0)
SP-0330: ULICE: Clinical cooperation in hadrontherapy born from the ULICE results (2014) (0)
Renaud Mazeron: A great scientist and teacher who contributed to GEC ESTRO for a decade. Tribute to Dr. Renaud Mazeron (1977-2016). (2018) (0)
Uveal Melanoma: Stereotactic Radiation Therapy (2019) (0)
88 poster: Combined MRI-Guided-BT With Chemoradiation in Advanced Poor Response Cervical Cancer FIGO IIB/IIIB (2009) (0)
242 oral BETWEEN GOLD STANDARD AND REALITY: IMAGE GUIDED ADAPTIVE BRACHYTHERAPY FOR CERVICAL CANCER PATIENTS, WITH MRI ONLY AT FIRST FRACTION (2011) (0)
2059 Quality control in electronic portal imaging devices (1995) (0)
73 oral: Midline Block Results in an Unpredictable Dose to Tumour and Organs-at-Risk When Used With Combined External Beam Radiotherapy and Brachytherapy in Locally Advanced Cervical Cancer: Results from a 3D MRI Based DVH Analysis (2009) (0)
85 Response to concurrent external beam radiotherapy and chemotherapy as a new predictor for overall survival in locally advanced cervical cancer – a retroembrace study nomogram (2019) (0)
87 A calculation model for dose-volume histograms based on serial intravascular ultrasound: Application for radioactive stents (2000) (0)
Dose Volume Effect Relationships (D0.1cm3, D2cm3) Predicting Late Rectal Morbidity in Patients Treated with Concomitant Chemoradiation and MRI-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: A Report from the EMBRACE Study (2016) (0)
PH-0403: Correlation early morbidity with external beam dose volume parameters in loc. advanced cervix cancer (2020) (0)
41 Technical and practical aspects of M RI/CT in brachytherapy treatment planning (2005) (0)
[Role of radiotherapy in esthesioneuroblastoma]. (1988) (0)
Katheterbasierte γ-HDR-Brachytherapie der peripheren Gefäße (2002) (0)
OC-0072: Risk factors for ureteral stricture after IGABT in cervical cancer: results from the EMBRACE studies (2018) (0)
In Reply to Dr. Dizdar et al. (2007) (0)
Clinical impact of dose volume adaptation and dose escalation in MRI-guided high-dose-rate brachytherapy including the use of combined intracavitary/interstitial techniques for patients with poor response cervical cancer FIGO stage IIB or IIIB (2009) (0)
Beta endovascular brachytherapy using CO2-filled centering catheter for in-stent restenosis of superficial femoral artery (2008) (0)
97: CARO Fellowship Image Guided Brachytherapy in Cervical Cancer: A Comparison Between Intracavitary and Combined Intracavitary/Interstitial Brachytherapy in Regard to Doses to HR CTV, Oars and Late Morbidity – Early Results from the Embrace Study in 999 Patients (2016) (0)
[Digital subtraction angiography (i.v. DSA) in the planning of infradiaphragmatic irradiation of malignant lymphoma]. (1989) (0)
Cooperative study of soft tissue sarcoma: First results (1997) (0)
PH-0404: Risk factors for late diarrhoea after radio(chemo)therapy in cervical cancer: EMBRACE I results (2020) (0)
OC-0262: Evaluation and comparison of a novel vaginal dose reporting method in 153 cervical cancer patients (2014) (0)
PO-0755: Organ shape variations influencing PTV concepts for cervix cancer ART (2015) (0)
Linking research and education: Gynaecologic brachytherapy as template for future estro activities? (2010) (0)
Percutaneous MR-guided high-dose-rate brachytherapy of liver metastasis (1999) (0)
OC-0264: Impact of inhomogeneity corrected dose calculation on dosimetric quality parameters in gynaecological cases (2014) (0)
Proctitis after Three-dimensional Conformal Radiotherapy of Localised Prostate Cancer. Classification According to the Vienna Rectoscopy Score and Correlation to the EORTC/RTOG Score within the Austrian–German Multicentre Prostate Cancer Trial (2006) (0)
OC-0086: Late morbidity following image guided adaptive brachytherapy (IGABT) in 533 patients with cervical cancer (2013) (0)
Extended field (EF) and total central lymphatic (TCl) radiotherapy for early stages nodal centroblastic-eentrocytic (CB-CC) lymphoma (1997) (0)
Progress in Radio-Oncology VIII (2007) (0)
311The role of radiotherapy in the multimodal treatment of Ewing's sarcoma of the chest walk (Askin tumors) (1996) (0)
[Calculation accuracy of volumes for evaluating dose-volume histograms. Comparison of various radiation planning systems]. (1998) (0)
Adaptive MR/CT Image-Guided Brachytherapy for Cervical Cancer Patients, With MRI Only at First Fraction (2011) (0)
IMAGE QUALITY AND STABILITY OF IMAGE GUIDED RADIOTHERAPY (IGRT) DEVICES: AN INTERCOMPARISON STUDY (2009) (0)
In Response to Dr. Wei and Colleagues (2011) (0)
732Electronic portal imaging assisted quality control of radiosurgery systems (1996) (0)
SP-0540: Dose delivery and impact of uncertainties on dose response in the clinical setting (2014) (0)
GEC-ESTRO study protocol for a European multicentre prospective trial of MRI 3-D image based treatment planning in cervix brachytherapy (2002) (0)
Advances in conformal therapy (1997) (0)
[Radiotherapy in (localized) non-Hodgkin's lymphoma of the orbit]. (1989) (0)
Preliminary results of carbon-11 acetate pet imaging in prostate cancer patients with rising PSA after radical therapy: clinical impact to choose appropriate further treatment strategies (2001) (0)
Brachytherapy for Uveal Melanoma (2002) (0)
Outcome of image guided brachytherapy in locally advanced cervical cancer within a multi-institutional retrospective cohort (2014) (0)
Adjuvant radiation therapy in the treatment of endometrial stromal sarcoma (ESS) (1999) (0)
PO-0867: Reporting of late morbidity after radiotherapy: review of the current practice in large studies (2018) (0)
Particle Therapy or Brachytherapy (2017) (0)
Long-term results of intensive breast conserving therapy including mainly quadrantectomy and high dose and large volume interstitial brachytherapy boost for T1/T2-breast cancer (2001) (0)
5 Modern Imaging in Brachytherapy (2003) (0)
80 Intratumoral P02 measurements as predictive assay in the treatment of primary cervical cancer (1998) (0)
D-conformal radiotherapy for inoperable non-small-cell lung cancer – A single centre experience (2007) (0)
580Radiation therapy in Vienna 11/1896 by L. Freund for a 4 year old girl with a pigmented piliferous naevus: details of treatment and outcome with a 77 years follow-up (1996) (0)
Quality assurance (QA) in pediatric radiotherapy (PR) (1993) (0)
16 Primary Vaginal Cancer (2003) (0)
Summary 7 Intraluminal Brachytherapy : Definition of Concepts , Doses and Volumes for Reporting 7 (2003) (0)
EMBRACE Study Dummy Run: Quality Assurance Procedure for Image-Guided Cervical Brachytherapy (2010) (0)
Quantitative and qualitative application of clinical drawings for image-guided brachytherapy in cervical cancer patients (2021) (0)
SP-0146: Patient perspective of quality. patient-reported outcomes vs physician reported outcomes (2015) (0)
Radiotherapy of Ocular Disease (1997) (0)
Late toxicity and cosmesis after APBI with brachytherapy vs WBI: 5-year results of a phase III trial (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Richard C. Pötter?

Richard C. Pötter is affiliated with the following schools:

Medical University of Vienna
University of Münster

Richard C. Pötter's Academic­Influence.com Rankings

Why Is Richard C. Pötter Influential?

Richard C. Pötter's Published Works

Published Works

What Schools Are Affiliated With Richard C. Pötter?

Richard C. Pötter's AcademicInfluence.com Rankings